Enovis (NYSE:ENOV) today announced Q3 results that beat the overall consensus on Wall Street. The Wilmington, Delaware-based orthopedics company reported profit losses of $2.8 million, or -36¢ per share, on sales of $417.5 million, for the three months ended September 29. Sales were up 8.78% compared with Q3 2022 and profits were up from the $66.5 […]
Enovis
Enovis to acquire LimaCorporate for more than $840M
Enovis (NYSE:ENOV) announced today that it entered into a definitive agreement to acquire orthopedic implant maker LimaCorporate. Wilmington, Delaware-based Enovis — one of the 10 largest orthopedic companies in the world — values the deal at approximately $846.4 million (€800 million). The deal includes a $740.6 million (€700 million) cash payment at closing. The remaining […]
The 10 largest orthopedic device companies in the world
Two of the world’s largest orthopedic device companies expect accelerated revenue growth this year. Stryker and Zimmer Biomet both upped their 2023 guidance during recent earnings calls, a sign that orthopedic procedures are bouncing back from the COVID-19 pandemic. GlobalData predicted earlier this year that the recovery will lift the ortho devices market to nearly $50 […]
Enovis completes Novastep acquisition
Enovis (NYSE: ENOV) announced today that it has completed its purchase of Novastep and its foot and ankle minimally invasive surgical (MIS) platform. The financial terms of the deal were undisclosed. Novastep generates about $20 million in annual revenue. “We are excited to welcome Novastep’s talented team to Enovis where we will work together to develop […]
Enovis Q1 results exceed expectations with 8% sales growth
Enovis (NYSE: ENOV) this week posted first-quarter results that beat the overall consensus on Wall Street. The Wilmington, Delaware-based company reported profit losses of $23.4 million, or 43¢ per share, on sales of $406.2 million, for the three months ended March 31, for a sales growth of 8.18% compared with Q1 2022. Profits slid from […]
Enovis to buy external fixation product line
Enovis (NYSE: ENOV) this week announced it signed a definitive agreement to acquire the Seal external fixation product line from DNE. The financial details of the deal were not disclosed. The company said the transaction is subject to customary closing conditions and is expected to close toward the end of the second quarter of 2023. […]
Enovis expands foot and ankle portfolio with knotless repair system
Enovis (NYSE: ENOV) today announced the expansion of its foot and ankle product line with the introduction of its Enofix with Constrictor technology. The company said the knotless syndesmotic repair system offers an improved solution for surgeons treating syndesmotic injuries, which commonly result from ankle fractures. The news system demonstrates superior fixation under cyclic loading, […]
Enovis to acquire Novastep to expand foot and ankle portfolio
Enovis (NYSE: ENOV) today announced it would acquire Novastep and its foot and ankle minimally invasive surgical (MIS) platform for an undisclosed amount. The transaction is subject to customary conditions and regulatory approvals. It is expected to close in the second quarter of 2023. Novastep generates about $20 million in annual revenue. Its MIS platform, […]
Enovis stock slides on Q4 revenue miss
Enovis (NYSE:ENOV) shares took a hit today on fourth-quarter results that fell shy of the consensus sales forecast. Shares of ENOV dropped 5.3% to $58.33 apiece in mid-afternoon trading today. The Wilmington, Delaware-based orthopedic device maker posted losses of $38.6 million. That amounts to losses of 71¢ per share on sales of $408.7 million for […]
Enovis expands foot and ankle portfolio with new staples
Enovis (NYSE: ENOV) today announced the launch of its procedure-specific DynaClip Delta and DynaClip Quattro bone staples. The staples are the latest additions to Wilmington, Delaware–based Enovis’ growing foot and ankle portfolio. The portfolio includes the DynaClip family of bone fixation systems. DynaClip Delta and DynaClip Quattro staples come pre-loaded on disposable inserters. The inserters […]
Enovis wins FDA nod for patient-specific Star Ankle instrumentation
Enovis (NYSE:ENOV) announced today that the FDA approved the STAR patient-specific instrumentation for use with the STAR total ankle replacement system. Wilmington, Delaware–based Enovis designed the STAR PSI system to provide a personalized preoperative plan for each patient. Surgeons receive and review a 3D visualization of the patient’s ankle joint. This includes information about existing […]
